title: Effect of age on ibuprofen pharmacokinetics and antipyretic response.
abstract: The effect of age on ibuprofen pharmacokinetics and antipyretic effect was studied in 49 infants and children aged 3 months to 10.4 years. The relationship of plasma concentration to antipyretic effect was examined in 38 of the children by using an iterative least squares technique that allows estimation of drug concentration with time in a theoretical effect compartment and rate constant for elimination of drug from the effect compartment. There was a delay of 1 to 3 hours between peak ibuprofen plasma concentration and peak temperature decrement. The mean elimination rate constant from the effect compartment was 0.6 hour-1, corresponding to a half-life of drug in the effect compartment of 1.1 hours. The mean slope of the effect compartment concentration versus temperature regression line was -0.242 degrees C/mg per liter. Age did not significantly influence the rate of absorption of ibuprofen, its plasma concentration, its rate of elimination, or the time course of ibuprofen concentration in the effect compartment. However, in younger children the onset of antipyresis was earlier, maximum antipyretic effect was greater, and the area under the curve of the percentage of change in temperature from baseline versus time was greater than in older children. We conclude that the greater relative body surface area in younger children may allow more efficient dissipation of heat in response to antipyretic-induced lowering of the temperature "set point" in the hypothalamus.
authors.affiliation: Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI.
authors.forename: R E
authors.initials: RE
authors.lastname: Kauffman
authors.forename: M V
authors.initials: MV
authors.lastname: Nelson
mesh_terms: D000208:Acute Disease; D000375:Aging / Q000378:metabolism*; D001365:Axilla; D001831:Body Temperature / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D005334:Fever / Q000097:blood* / Q000188:drug therapy / Q000453:epidemiology; D006207:Half-Life; D006801:Humans; D007052:Ibuprofen / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D007223:Infant; D008297:Male; D012044:Regression Analysis; D013535:Suspensions; D013997:Time Factors
chemical_list: D013535:Suspensions; D007052:Ibuprofen